Because this association was significant among patients with ER-positive tumors who were lymph node negative at the time of diagnosis (Figure 8A), this finding indicated that ARID4B expression level is predictive of patient progression to metastatic disease. This evidence concerns the gene ARID4B and metastatic neoplasm.